{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:07:17Z","timestamp":1793084837345,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008052","name":"Fundaci\u00f3n Alfonso Mart\u00edn Escudero","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10557-016-6673-2","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T01:08:53Z","timestamp":1466644133000},"page":"445-453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Exogenous Administration of Recombinant MIF at Physiological Concentrations Failed to Attenuate Infarct Size in a Langendorff Perfused Isolated Mouse Heart Model"],"prefix":"10.1007","volume":"30","author":[{"given":"Xavier","family":"Rossello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Stoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Bernhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek M.","family":"Yellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,22]]},"reference":[{"key":"6673_CR1","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","volume":"357","author":"DM Yellon","year":"2007","unstructured":"Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357:1121\u201335.","journal-title":"N Engl J Med"},{"key":"6673_CR2","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jacc.2015.02.032","volume":"65","author":"B Ib\u00e1\u00f1ez","year":"2015","unstructured":"Ib\u00e1\u00f1ez B, Heusch G, Ovize M, Van de Werf F. Evolving therapies for myocardial ischemia\/reperfusion injury. J Am Coll Cardiol. 2015;65:1454\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"6673_CR3","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/CIRCULATIONAHA.107.729125","volume":"117","author":"A Zernecke","year":"2008","unstructured":"Zernecke A, Bernhagen J, Weber C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation. 2008;117:1594\u2013602.","journal-title":"Circulation"},{"key":"6673_CR4","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nature06504","volume":"451","author":"EJ Miller","year":"2008","unstructured":"Miller EJ, Li J, Leng L, McDonald C, Atsumi T, Bucala R, et al. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature. 2008;451:578\u201382.","journal-title":"Nature"},{"key":"6673_CR5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1160\/TH15-05-0436","volume":"115","author":"J Pohl","year":"2015","unstructured":"Pohl J, Hendgen-Cotta UB, Rammos C, Luedike P, Mull E, Stoppe C, et al. Targeted intracellular accumulation of macrophage migration inhibitory factor in the reperfused heart mediates cardioprotection. Thromb Haemost. 2015;115:200\u201312.","journal-title":"Thromb Haemost"},{"key":"6673_CR6","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/ATVBAHA.113.301633","volume":"33","author":"EA Liehn","year":"2013","unstructured":"Liehn EA, Kanzler I, Konschalla S, Kroh A, Simsekyilmaz S, S\u00f6nmez TT, et al. Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia\/reperfusion. Arterioscler Thromb Vasc Biol. 2013;33:2180\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6673_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/cvr\/cvu071","volume":"102","author":"T Rassaf","year":"2014","unstructured":"Rassaf T, Weber C, Bernhagen J. Macrophage migration inhibitory factor in myocardial ischaemia\/reperfusion injury. Cardiovasc Res. 2014;102:321\u20138.","journal-title":"Cardiovasc Res"},{"key":"6673_CR8","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI39738","volume":"119","author":"D Qi","year":"2009","unstructured":"Qi D, Hu X, Wu X, Merk M, Leng L, Bucala R, et al. Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia\/reperfusion. J Clin Invest. 2009;119:3807\u201316.","journal-title":"J Clin Invest"},{"key":"6673_CR9","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1089\/ars.2010.3163","volume":"14","author":"K Koga","year":"2011","unstructured":"Koga K, Kenessey A, Powell SR, Sison CP, Miller EJ, Ojamaa K. Macrophage migration inhibitory factor provides cardioprotection during ischemia\/reperfusion by reducing oxidative stress. Antioxid Redox Signal. 2011;14:1191\u2013202.","journal-title":"Antioxid Redox Signal"},{"key":"6673_CR10","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1161\/CIRCULATIONAHA.111.069104","volume":"125","author":"P Luedike","year":"2012","unstructured":"Luedike P, Hendgen-Cotta UB, Sobierajski J, Totzeck M, Reeh M, Dewor M, et al. Cardioprotection through S-nitros(yl)ation of macrophage migration inhibitory factor. Circulation. 2012;125:1880\u20139.","journal-title":"Circulation"},{"key":"6673_CR11","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1038\/sj.onc.1210318","volume":"26","author":"H Lue","year":"2007","unstructured":"Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, et al. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5\/JAB1 in the control of autocrine MIF activity. Oncogene. 2007;26:5046\u201359.","journal-title":"Oncogene"},{"key":"6673_CR12","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/CIRCRESAHA.115.305171","volume":"115","author":"M Chatterjee","year":"2014","unstructured":"Chatterjee M, Borst O, Walker B, Fotinos A, Vogel S, Seizer P, et al. Macrophage migration inhibitory factor limits activation-induced apoptosis of platelets via CXCR7-dependent Akt signaling. Circ Res. 2014;115:939\u201349.","journal-title":"Circ Res"},{"key":"6673_CR13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.RES.0000087641.56024.DA","volume":"93","author":"MA Amin","year":"2003","unstructured":"Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE. Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res. 2003;93:321\u20139.","journal-title":"Circ Res"},{"key":"6673_CR14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092827","volume":"9","author":"A Goetzenich","year":"2014","unstructured":"Goetzenich A, Kraemer S, Rossaint R, Bleilevens C, Dollo F, Siry L, et al. The role of macrophage migration inhibitory factor in anesthetic-induced myocardial preconditioning. PLoS One. 2014;9:e92827.","journal-title":"PLoS One"},{"key":"6673_CR15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/CIRCULATIONAHA.112.000862","volume":"128","author":"J Wang","year":"2013","unstructured":"Wang J, Tong C, Yan X, Yeung E, Gandavadi S, Hare AA, et al. Limiting cardiac ischemic injury by pharmacological augmentation of macrophage migration inhibitory factor-AMP-activated protein kinase signal transduction. Circulation. 2013;128:225\u201336.","journal-title":"Circulation"},{"key":"6673_CR16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1089\/ars.2014.6243","volume":"23","author":"C Stoppe","year":"2015","unstructured":"Stoppe C, Rex S, Goetzenich A, Kraemer S, Emontzpohl C, Soppert J, et al. Interaction of MIF family proteins in myocardial ischemia\/reperfusion damage and their influence on clinical outcome of cardiac surgery patients. Antioxid Redox Signal. 2015;23:865\u201379.","journal-title":"Antioxid Redox Signal"},{"key":"6673_CR17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000226","volume":"2","author":"W Chan","year":"2013","unstructured":"Chan W, White DA, Wang X-Y, Bai R-F, Liu Y, Yu H-Y, et al. Macrophage migration inhibitory factor for the early prediction of infarct size. J Am Heart Assoc. 2013;2:e000226.","journal-title":"J Am Heart Assoc"},{"key":"6673_CR18","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.yjmcc.2010.12.022","volume":"50","author":"X-M Gao","year":"2011","unstructured":"Gao X-M, Liu Y, White D, Su Y, Drew BG, Bruce CR, et al. Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia\u2013reperfusion injury: a predominant role of anti-inflammation. J Mol Cell Cardiol. 2011;50:991\u20139.","journal-title":"J Mol Cell Cardiol"},{"key":"6673_CR19","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.RES.0000130526.20854.fa","volume":"94","author":"M Nian","year":"2004","unstructured":"Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004;94:1543\u201353.","journal-title":"Circ Res"},{"key":"6673_CR20","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1161\/01.RES.0000168327.22888.4d","volume":"96","author":"F Chagnon","year":"2005","unstructured":"Chagnon F, Metz CN, Bucala R, Lesur O. Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization. Circ Res. 2005;96:1095\u2013102.","journal-title":"Circ Res"},{"key":"6673_CR21","doi-asserted-by":"crossref","first-page":"H2500","DOI":"10.1152\/ajpheart.00432.2003","volume":"285","author":"LB Garner","year":"2003","unstructured":"Garner LB, Willis MS, Carlson DL, DiMaio JM, White MD, White DJ, et al. Macrophage migration inhibitory factor is a cardiac-derived myocardial depressant factor. Am J Physiol Heart Circ Physiol. 2003;285:H2500\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6673_CR22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.110.953208","volume":"122","author":"H Ma","year":"2010","unstructured":"Ma H, Wang J, Thomas DP, Tong C, Leng L, Wang W, et al. Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart. Circulation. 2010;122:282\u201392.","journal-title":"Circulation"},{"key":"6673_CR23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-2828(02)00310-3","volume":"35","author":"RM Bell","year":"2003","unstructured":"Bell RM, Yellon DM. Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS. J Mol Cell Cardiol. 2003;35:185\u201393.","journal-title":"J Mol Cell Cardiol"},{"key":"6673_CR24","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.yjmcc.2011.02.018","volume":"50","author":"RM Bell","year":"2011","unstructured":"Bell RM, Mocanu MM, Yellon DM. Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. J Mol Cell Cardiol. 2011;50:940\u201350.","journal-title":"J Mol Cell Cardiol"},{"key":"6673_CR25","doi-asserted-by":"crossref","unstructured":"Rossello X, Hall AR, Bell RM, Yellon DM. Characterization of the Langendorff perfused isolated mouse heart model of global ischemia\u2013reperfusion injury: impact of ischemia and reperfusion length on infarct size and LDH release. J Cardiovasc Pharmacol Ther. 2016;21(3):286\u201395.","DOI":"10.1177\/1074248415604462"},{"key":"6673_CR26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00430828","volume":"393","author":"HH Klein","year":"1981","unstructured":"Klein HH, Puschmann S, Schaper J, Schaper W. Vircho Archiv a the mechanism of the Tetrazolium reaction in identifying experimental myocardial infarction. Virchows Arch [Pathol Anat]. 1981;393:287\u201397.","journal-title":"Virchows Arch [Pathol Anat]"},{"key":"6673_CR27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00395-014-0422-0","volume":"109","author":"J Garc\u00eda-Prieto","year":"2014","unstructured":"Garc\u00eda-Prieto J, Garc\u00eda-Ruiz JM, Sanz-Rosa D, Pun A, Garc\u00eda-Alvarez A, Davidson SM, et al. \u03b23 adrenergic receptor selective stimulation during ischemia\/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes. Basic Res Cardiol. 2014;109:422.","journal-title":"Basic Res Cardiol"},{"key":"6673_CR28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412.","journal-title":"PLoS Biol"},{"key":"6673_CR29","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/6e24b7bb-83c7-4887-9621-96b64acfb1c1","volume":"8","author":"DA White","year":"2013","unstructured":"White DA, Fang L, Chan W, Morand EF, Kiriazis H, Duffy SJ, et al. Pro-inflammatory action of MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells. PLoS One. 2013;8:e76206.","journal-title":"PLoS One"},{"key":"6673_CR30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jacc.2014.11.004","volume":"65","author":"R Fern\u00e1ndez-Jim\u00e9nez","year":"2015","unstructured":"Fern\u00e1ndez-Jim\u00e9nez R, S\u00e1nchez-Gonz\u00e1lez J, Ag\u00fcero J, Garc\u00eda-Prieto J, L\u00f3pez-Mart\u00edn GJ, Garc\u00eda-Ruiz JM, et al. Myocardial edema after ischemia\/reperfusion is not stable and follows a bimodal pattern. J Am Coll Cardiol. 2015;65:315\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"6673_CR31","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jacc.2015.06.023","volume":"66","author":"R Fern\u00e1ndez-Jim\u00e9nez","year":"2015","unstructured":"Fern\u00e1ndez-Jim\u00e9nez R, Garc\u00eda-Prieto J, S\u00e1nchez-Gonz\u00e1lez J, Ag\u00fcero J, L\u00f3pez-Mart\u00edn GJ, Gal\u00e1n-Arriola C, et al. Pathophysiology underlying the bimodal edema phenomenon after myocardial ischemia\/reperfusion. J Am Coll Cardiol. 2015;66:816\u201328.","journal-title":"J Am Coll Cardiol"},{"key":"6673_CR32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1042\/CS20130828","volume":"127","author":"NH Dayawansa","year":"2014","unstructured":"Dayawansa NH, Gao X-M, White DA, Dart AM, Du X-J. Role of MIF in myocardial ischaemia and infarction: insight from recent clinical and experimental findings. Clin Sci (Lond). 2014;127:149\u201361.","journal-title":"Clin Sci (Lond)"},{"key":"6673_CR33","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1172\/JCI73061","volume":"124","author":"D Qi","year":"2014","unstructured":"Qi D, Atsina K, Qu L, Hu X, Wu X, Xu B, et al. The vestigial enzyme D-dopachrome tautomerase protects the heart against ischemic injury. J Clin Invest. 2014;124:3540\u201350.","journal-title":"J Clin Invest"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-016-6673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-016-6673-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-016-6673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:53:46Z","timestamp":1498308826000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-016-6673-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,22]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["6673"],"URL":"https:\/\/doi.org\/10.1007\/s10557-016-6673-2","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,22]]}}}